Stay updated on Early Ixekizumab Activity in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Early Ixekizumab Activity in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Early Ixekizumab Activity in Psoriasis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A Locations section is added that lists New York as a study site, replacing the former New York Locations entry. The HHS Vulnerability Disclosure section is removed and the revision label updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:43:28.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.3.1 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-01T17:28:15.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.1, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:47:18.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Removed a government funding status notice that previously appeared on this page; no study content, endpoints, or eligibility information were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:30:16.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page shows a revised layout with updated sections and visual banners, while the core study details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:10:56.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    4%
    Check dated 2025-10-05T09:46:25.000Z thumbnail image

Stay in the know with updates to Early Ixekizumab Activity in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Early Ixekizumab Activity in Psoriasis Clinical Trial page.